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Abstract
Purpose: To demonstrate the feasibility of using an inversion recovery pulse sequence and to
define the optimal inversion time (TI) to assess myocardial infarction in mice by late gadolinium
enhancement (LGE) MRI at 9.4T, and to obtain the maximal contrast between the infarcted and the
viable myocardium.
Methods: MRI was performed at 9.4T in mice, two days after induction of myocardial infarction
(n = 4). For cardiovascular MR imaging, a segmented magnetization-prepared fast low angle shot
(MP-FLASH) sequence was used with varied TIs ranging from 40 to 420 ms following administration
of gadolinium-DTPA at 0.6 mmol/kg. Contrast-to-noise (CNR) and signal-to-noise ratio (SNR)
were measured and compared for each myocardial region of interest (ROI).
Results: The optimal TI, which corresponded to a minimum SNR in the normal myocardium, was
268 ms ± 27.3. The SNR in the viable myocardium was significantly different from that found in the
infarcted myocardium (17.2 ± 2.4 vs 82.1 ± 10.8; p = 0.006) leading to a maximal relative SI (Signal
Intensity) between those two areas (344.9 ± 60.4).
Conclusion: Despite the rapid heart rate in mice, our study demonstrates that LGE MRI can be
performed at 9.4T using a protocol similar to the one used for clinical MR diagnosis of myocardial
infarction.
Introduction
Late Gadolinium Enhancement (LGE) cardiovascular
magnetic resonance (CMR) imaging using a T1-weighted
sequence with an inversion recovery (IR) pre-pulse is
commonly used for the clinical diagnosis of myocardial
infarction in humans [1,2], and experimentally in large
animals [3]. The time to inversion (TI) is selected to null
the signal intensity (SI) in the non-infarcted (viable) myo-
cardium, following administration of chelated gadolin-
ium, in order to increase contrast between the viable and
hyper-enhanced infarcted myocardium [1]. Late gadolin-
ium enhancement MR imaging with inversion recovery
techniques has been shown to correlate well as an early
marker of irreversible injury and eventual fibrosis [3].
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More recently, the mouse model has been used increas-
ingly for investigating the mechanisms of myocardial dis-
eases. Hence, its essential to assess myocardial infarction
in pre-clinical models in a manner similar to that used for
clinical diagnosis. At present the assessment of infarct size
in small animals at high magnetic fields is performed
using a 'cine gradient echo pulse sequence' with a high
dose of gadolinium chelates [4]. However, this type of MR
protocol is limited in its ability to accurately delineate the
infarcted tissue from the normal non-infarcted myocar-
dium [1,5]. A number of discrepancies have also been
observed between different studies using LGE, due princi-
pally to the use of differing protocols, including dissimilar
MR sequences for imaging acquisition, different delay
periods after administration of contrast agent, and even
different animal models of MI. However, the use of an
inversion recovery T1-weighted approach has become an
accepted modality for the clinical diagnosis of myocardial
infarction [6,7]. Nevertheless, this approach has not been
extensively described in the literature for cardiac MR stud-
ies in small animals at high magnetic field (such as 9.4T),
due to the rapid heart rate (500–600 bpm in mice and
300–400 bpm in rats) [4].
Thus, the aims of the present study were firstly, to demon-
strate the feasibility of using an inversion recovery pulse
sequence to assess myocardial infarction in mice follow-
ing administration of gadolinium chelate, and secondly,
to define the optimal inversion time for myocardial inf-
arction MR imaging at 9.4T in order to discriminate the
infarcted tissue from the non-infarcted myocardium.
Methods
Animal model
All studies were performed in accordance with the Ani-
mals (Scientific Procedures) Act 1986 (UK) and local
institutional guidelines. During the surgical procedure,
male C57Bl/6 mice (10–12 weeks old, 25–30 g, Harlan,
UK; n = 4) were anaesthetized with 1.5–2% isoflurane-
oxygen mixture, intubated and ventilated using a small
animal ventilation apparatus (VetTech Solutions Ltd,
UK). Following thoracotomy, myocardial infarction was
achieved by permanent ligation of the left coronary artery
using a 7-0 silk suture tied around the left anterior
descending coronary artery approximately 1–2 mm from
its origin. The ischemic area was identified visually as a
result of blanching of the tissue upon ligation.
CMR imaging
Two days after myocardial infarction, cardiovascular MR
imaging was performed on a 9.4T horizontal MR scanner
(Varian, Palo Alto, CA, USA), using an eight rod quadra-
ture birdcage transmit/receive coil with an internal diam-
e t e r  o f  2 5  m m  a n d  a  l e n g t h  o f  2 5  m m  ( M a g n e t i c
Resonance Laboratories, Oxford, UK). The gradient
strength was 20 G/cm with a rise time of 90 usec.
For late gadolinium enhanced MR imaging, a 0.6 mmol/
kg bolus of Gd-DTPA (Magnevist, Schering Healthcare,
UK) was injected intravenously through the tail vein using
a 27G catheter. ECG was recorded with a monitoring and
gating system (SA Instruments, Inc. Stony Brook, NY,
USA), to provide a trigger pulse at the R-wave signal. Scout
Gradient echo images were acquired in order to obtain the
short-axis plan of the heart. Imaging was initiated imme-
diately after the injection of Gd-DTPA using an ECG-gated
segmented magnetization-prepared FLASH sequence. The
following parameters were used for image acquisition:
TReff~120 ms; TE = 2.2 ms; FOV = 25 × 25 mm; matrix
128 × 128; flip angle = 30°; 20 averages; 16 segments, giv-
ing 8 phase encode steps per cardiac cycle. Thus, the data
acquisition time per inversion pulse within each cardiac
cycle was 18 msec, to ensure the imaging was performed
in a short window centred at the null point. We used seg-
mented k-space to decrease the total imaging time and to
ensure consistent contrast across the image. By collecting
8 phase encode steps at a time we kept k-space centred
around the null point of the T1 recovery. A midventricular
short axis slice of 1.2 mm was selected for this study. The
TI for this sequence was defined as the time between the
non-selective adiabatic IR pulse and the 30° flip angle RF
pulse. TI varied as follows: 20 points were obtained where
TI of the first image was 40 ms, with subsequent TI
applied at 20 ms intervals i.e. from 40 to 420 ms. The k-
space lines were acquired in center-out interleaved linear
order (Figure 1). CMR imaging was initiated immediately
after contrast injection and continued for 45 minutes.
Diagram of MR imaging with inversion recovery magnetiza- tion-prepared fast low angle shot (MP-FLASH) pulse  sequence Figure 1
Diagram of MR imaging with inversion recovery magnetiza-
tion-prepared fast low angle shot (MP-FLASH) pulse 
sequence. IR = inversion recovery pulse; ECG = electrocar-
diogram; AW = acquisition window; TI = inversion time 
(optimal inversion is TI0 = TI to null uninfarcted myocar-
dium); TReff = effective repetition time (depending on TI and 
heart beat).Journal of Cardiovascular Magnetic Resonance 2008, 10:6 http://www.jcmr-online.com/content/10/1/6
Page 3 of 7
(page number not for citation purposes)
MR image analysis
MRI images have been evaluated according to the proto-
col reported by Gupta et al [2], where the optimal TI (TI0)
was defined visually as the value at which the signal inten-
sity (SI) of the viable myocardium was nulled. Signal
intensities were measured in 2 to 3 regions of interest
(ROIs) from the most intense portion of the hyper-
enhanced segments corresponding to the infarcted myo-
cardium, 3 ROIs in blood pool in the left ventricle and 3
ROIs in the viable myocardium. The noise was measured
in a region undegraded by artefacts. Signal-to-noise ratios
(SNRs) for different cardiac regions were calculated by
dividing each mean SI by the standard deviation (SD) of
the noise. The SNRs for all TI values were plotted for each
mouse, and the SNR for the optimal TI was compared
with the SNR of other TIs. The contrast-to-noise ratios
(CNR) for the infarcted myocardium compared with the
viable myocardium was defined as (SIinf - SIviable)/SDnoise.
The relative SI (expressed as a percentage) of the infarcted
myocardium compared with the viable myocardium was
defined as [(SIinf-SIviable)/SIviable] × 100. The relative SI
(expressed as a percentage) of the blood pool compared
with the viable myocardium was defined as [(SIblood-SIvia-
ble)/SIviable] × 100.
Post-mortem analysis
Following image acquisition, animals were euthanized.
The heart was excised and sectioned into 1 mm thick slices
along the short axis and the presence of myocardial infarc-
tion was confirmed by incubation of heart slices in 2,3,5-
triphenyltetrazolium chloride (TTC) for 20 minutes at
37°C.
Statistical analysis
All values were expressed as the mean plus or minus the
standard error of the mean (± SEM). SNR and CNR of dif-
ferent regions of interest and the relative SIs (%) between
regions of interest over time were compared with ANOVA
of repeated measurements. Multiple comparisons were
analysed by the Bonferroni method. Values of P < 0.05
were considered statistically significant.
Results
Transmural myocardial infarction was confirmed in all
mice using TTC staining (Figure 2). The TI0 was defined as
the TI value, which nulls the SI of the non-infarcted (via-
ble) myocardium. This value was unique for each mouse
and ranged from 220 to 300 msec (Figure 3). The SNR in
the viable myocardium was at its minimum (17.2 ± 2.4,
ranging from 12.8 to 23.1) for a mean TI of 268 msec ±
27.3 corresponding to the optimal TI (referred to as TI0).
Mean SNR, CNR and relative SI at TI0 are reported in Table
a) Short-axis MR images performed 45 minutes post-injection using a TI of 300 msec and b) corresponding post-mortem  image following TTC staining Figure 2
a) Short-axis MR images performed 45 minutes post-injection using a TI of 300 msec and b) corresponding post-mortem 
image following TTC staining. Arrows indicate the infarcted myocardium defined using MRI (a) and post-mortem TTC staining 
(b).Journal of Cardiovascular Magnetic Resonance 2008, 10:6 http://www.jcmr-online.com/content/10/1/6
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1. The minimum SNR, at TI0, in the viable myocardium
(17.2 ± 2.4) was significantly different from that found in
the infarcted myocardium (82.1 ± 10.8; p = 0.006) but not
from the SNR in the blood (48.7 ± 16.6, p = 0.126). The
mean CNR of infarcted tissue compared with viable myo-
cardium was 76.6 ± 19.8, whereas infarcted tissue com-
pared with blood was 25.7 ± 14.7, and blood compared
with viable myocardium was 40.6 ± 21.2. The mean max-
imum relative SI of the infarcted tissue compared with via-
ble myocardium was 344.9 ± 60.4% (Figure 4), and
occurred at TI0 when SI of the viable myocardium was
minimum, leading to an optimal CNR between viable and
infarcted myocardial areas.
Short-axis cardiovascular MR images corresponding to each inversion time (TI) following Gd-DTPA injection (the dotted line  shows the hyperenhanced area corresponding to the infarcted myocardium at 30 minutes post-Gd-DOTA injection) Figure 3
Short-axis cardiovascular MR images corresponding to each inversion time (TI) following Gd-DTPA injection (the dotted line 
shows the hyperenhanced area corresponding to the infarcted myocardium at 30 minutes post-Gd-DOTA injection).Journal of Cardiovascular Magnetic Resonance 2008, 10:6 http://www.jcmr-online.com/content/10/1/6
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The mean relative SI of infarcted compared with viable
myocardium was determined at differing TI values; where
TI-1, TI+1, TI+2 and TI+2 are 20 msec intervals around TI0
(Figure 4). The mean relative SIs (%) of the infarcted myo-
cardium compared with viable myocardium at TI0 (344.9
± 60.4%) was significantly different (p < 0.05) using the
Bonferroni test at TI-1 (209.3 ± 48.0), at TI-2 (190.2 ±
31.8), at TI+1 (269.8 ± 47.3) and at TI+2 (211.9 ± 46.3).
Discussion
For both technical and economic reasons, the mouse is
currently the most commonly used mammal for studying
whole body function and dysfunction. It is therefore
important to develop tools that allow the study of mouse
models that recapitulate the human disease process under
investigation. For cardiac diseases, a range of physiologi-
cal measures can be used to assess heart morphology and
function (echocardiography, conductance volumetry,
sonomicrometry and magnetic resonance imaging), pres-
sure, flow, and electrophysiology [8]. Here we report on
the feasibility of using high-field MRI to delineate myo-
cardial infarction, with late gadolinium enhancement and
an inversion recovery pulse sequence in mice, despite
their rapid heart rate (~500 bpm). To our knowledge, this
is the first study to demonstrate that an inversion recovery
pulse sequence can be used to discriminate infarcted from
non-infarcted myocardium in small rodents at 9.4T.
The implementation of an inversion recovery T1-weighted
sequence, where the inversion time (TI) is selected to null
signal intensity (SI) from the non-infarcted myocardium
after the administration of a contrast agent, has improved
the contemporary diagnosis of myocardial infarction, and
this approach is now used commonly in the clinic [1,9-
11]. The main advantage of using an inversion recovery
pulse sequence for late gadolinium enhancement MRI is
its ability to accurately identify both viable and non-via-
ble myocardium post-infarction. Indeed, hyper-enhance-
ment occurs in the non-viable myocardium due the
passive diffusion of gadolinium into the intracellular
space because of dysfunctional myocyte membranes [12].
The combination of IR pulse sequence and administration
of contrast agent, allows a clear and highly reproducible
delineation of hyper-enhanced regions corresponding to
the infarcted, non-viable myocardial tissues. Indeed, the
post-infarction discrimination between viable and non-
viable myocardium, is critical in monitoring prognosis
and therapeutic interventions [13]. Moreover, similar
studies on large animal models have confirmed the strong
correlation between infarct size, as visualised by adminis-
tration of contrast agent together with use of IR pulse
sequence, and subsequent post-mortem analysis [3,14].
Our study demonstrates that the TI, which nulls the signal
in the non-infarcted myocardium, was 268 msec ± 27.3
(ranged from 220 to 300 msec). Although this value was
obtained at high magnetic field strengths, which results in
increased longitudinal relaxation times, the optimal TI is
nevertheless comparable to that of many clinical studies.
Indeed, Gupta et al [2] reported an optimal TI of 260.6
msec ± 38.4 (ranged from 180 to 315 msec) in human
subjects, following a bolus injection of gadolinium (0.15
mmol/kg) at 1.5T. The optimized inversion time for myo-
cardial infarction imaging in rabbits was found to be
between 180 and 240 msec following 0.1 mmol/kg of Gd-
DTPA at 1.5T [15]. Since the high magnetic field leads to
an increase of the longitudinal relaxation times, it was
anticipated that the TI values in our study would to be
higher. Hence, our results may be explained by the effect
of 9.4T on the high dose of gadolinium, inducing a larger
decrease in T1 than expected. Li et al [16] reported a rapid
decrease, by half, in T1 values of normal pig myocardium
following a Gd-DTPA dose of 0.05 mmol/kg at 7T. In the
present study, a gadolinium dose of 0.6 mmol/kg was
used, which is in the range reported for previous animal
studies [4], but which may have induced a more signifi-
Table 1: SNR, contrast-to-noise ratio, and relative SI values in 
different regions of interest in myocardium at TI0.
a) SNR:
Normal myocardium 17.2 ± 2.4*
Infarcted myocardium 82.1 ± 10.8
Blood 48.7 ± 16.6
b) Contrast-to-noise ratio:
Infarcted compared with normal myocardium 76.6 ± 19.8
Infarcted compared with blood 25.7 ± 14.7
Blood compared with normal myocardium 40.6 ± 21.2
c) Relative SI (%)
Infarcted compared with normal myocardium 344.9 ± 60.4
Blood compared with normal myocardium 144.6 ± 77.3
Mean (± SEM) (*p < 0.05 viable vs infarcted myocardium).
Mean relative SI (%) (± SEM) of infarcted compared with via- ble myocardium at varying TIs Figure 4
Mean relative SI (%) (± SEM) of infarcted compared with via-
ble myocardium at varying TIs.Journal of Cardiovascular Magnetic Resonance 2008, 10:6 http://www.jcmr-online.com/content/10/1/6
Page 6 of 7
(page number not for citation purposes)
cant decrease in T1 values than predicted. However, when
compared to Schneider et al's T1 values of 1.1 ± 0.3 sec-
onds at 11.7T for the viable left ventricle myocardium in
mice [17] and Li et al's observations following Gd-DTPA
injection, our study performed at 9.4T yielded relatively
low TI values, and are thus reasonable. Similarly, Wagner
et al [3] reported that at 1.5T, the inversion times selected
to null the signal in viable myocardium were higher for a
contrast agent dose of 0.1 mmol/kg than for 0.2 mmol/kg.
Moreover, the TI could change over time following gado-
linium injection, predominantly due to a decrease in con-
centration of the contrast agent in myocardial tissues
[3,6,12]. In our study, the signal intensities in the blood
and in the infarcted myocardium were less discriminating,
leading to difficulty in visual delineation of the two terri-
tories. This was probably due to the relatively high dose of
the contrast agent, and the delay between injection and
initiation of the imaging acquisition [1]. In retrospect, it
would have been helpful to wait longer for the contrast
agent to wash out of the blood pool; nevertheless, we
found the optimal TI (~270 ms) at a post-injection delay
of about 28 minutes.
The higher heart rate in rodents demands an ultrafast
imaging protocol to minimize motion artefacts. This
rapid heart rate also made it difficult to use cardiac trigger-
ing, and moreover, the TR was not fixed, which varied
from ~100 ms to 420 ms. It is also important to note that
the maximum TI (420 ms) corresponded to ~4 R-R inter-
vals, which may have influenced the CNR values between
different myocardial areas. Thus, the contrast observed
between the blood, the infarcted and the viable myocar-
dium in the T1-weighted late gadolinium enhanced
image, depends on multiple variables such as contrast
agent concentration, delay between gadolinium-chelate
injection and MR acquisition, clearance rate, and imaging
parameters. Blood velocity may also have a role in the
contrast, which explains our low CNR between infarcted
myocardium and blood [18]. Nevertheless, the present
protocol allows the acquisition of workable images in less
than 3 minutes, and also allows total TI mapping in less
than 45 minutes.
Although respiratory gating may be used to minimize
motion related-artefacts, especially at high magnetic fields
[17], this approach was not used in our study as respira-
tory induced motion artefacts were not visible, and there-
fore had no affect on the definition and contrast across the
images. Furthermore, we used serial averaging (20 signal
averages) to reduce any residual respiratory artefacts.
Moreover, previous studies have also commented on pres-
ence of negligible artefacts in mouse heart imaging due to
respiratory motion. It was argued that the ratio of breath-
ing to heart rate was lower (1:8) for anesthetized mice, rel-
ative to either larger animals or humans [19]. Although,
isoflurane, the anaesthetic of choice used in these studies,
depresses the overall heart rate, it nevertheless maintains
physiologic heart rates and stable heart function [20,21].
In conclusion, we have demonstrated the feasibility of
performing late gadolinium enhancement using an IR
sequence in mice at 9.4T. Our approach leads to a high
CNR between infarcted and non-infarcted myocardium,
using a protocol comparable to that used for clinical MR
diagnosis of myocardial infarction. Hence, with the
increasing use pre-clinical models to investigate cardiac
dysfunction, the implementation of such methodologies
are a prerequisite for the accurate delineation between inf-
arcted and non-infarcted myocardium in small animals,
in order to allow further development of therapeutic
interventions.
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